Advanced Course in Basic & Clinical Immunology
February 19-22, 2017
Fire Sky Resort & Spa
Scottsdale, Arizona, USA
The IUIS Gender Equality and Career Development Committee (GEC) in collaboration with the Federation of Clinical Immunology Societies (FOCIS) will co-sponsor 4 trainees from the developing world to attend this course. IUIS will pay for a travel bursary of $2,000 US maximum, while FOCIS will pay for registration, 4 nights accommodation and meals during the conference. Additional expenses will be the responsibility of the student.
This initiative has been very successful in the last 8 years and students really appreciated. The candidates should have sufficient scientific background and comprehension of English to benefit maximally from the Advanced Course. Prominent speakers will lecture on topics in cellular and molecular immunology, including innate immunity, B & T cells, and cytokines. Special sessions will cover new advances in clinical immunology and the molecular and genetic basis of immune-mediated diseases. There will be ample opportunity for attendees to interact with the faculty inside and outside the lecture room. The target audience includes clinical fellows in disciplines related to immunology (such as rheumatology, allergy, infectious disease, oncology and transplantation) and graduate students and fellows doing basic research with an emphasis on human disease.
Please visit the following website to find out more about the course, schedule, speakers, and presentation titles.
The GEC Committee will do the selection of candidates for the four awards.
The applicants are advised not to register on line for this course if applying for the FOCIS/IUIS support. A brief CV, a statement in 250 words outlining how you would you benefit from this course and a letter of recommendation/reference from a professor or mentor must be sent by email to Dr. Narinder Mehra, email: email@example.com.
Application deadline: December 1st, 2016, in order to allow time for US VISA.
Only the awardees will be notified by December 20th.